InsiderTrades

Cavu Management, LP

SEC CIK 1813270 · EDGAR

Buying vs selling by month open-market trades, last 50 months, all 3 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
LTRNLantern Pharma Inc.10% 371.9K — $2.04M 22022-11-082023-11-29
CGTXCOGNITION THERAPEUTICS INC10% 316.0K $1.80M — 12022-11-152022-11-15
INABIN8BIO, INC.Dir, 10% 3.61M $96.5K — 12022-08-172022-08-17

Most active insiders at LTRN, 12 months

#InsiderTitleBoughtSold
1 Schalop Lee TroyDir $100.0K—
2 KEYSER D JEFFREYDir $100.0K—

Cavu Management, LP made no open-market trades at LTRN in the last 12 months.

Transactions 4

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
MI 2023-12-01 2023-11-29 LTRN Lantern Pharma Inc. Cavu Management, LP 10% S - Sale $3.44 -145.3K 371.9K -28% -$500.0K
MI 2022-11-16 2022-11-15 CGTX COGNITION THERAPEUTICS INC Cavu Management, LP 10% P - Purchase $1.20 +1.50M 316.0K New +$1.80M
MI 2022-11-09 2022-11-08 LTRN Lantern Pharma Inc. Cavu Management, LP 10% S - Sale $4.40 -350.0K 463.7K -43% -$1.54M
MI 2022-08-18 2022-08-17 INAB IN8BIO, INC. Cavu Management, LP Dir, 10% P - Purchase $1.93 +50.0K 3.61M +1% +$96.5K

Purchase Sale Sale after option exercise All abbreviations